Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

What is the impact of blood-pressure control on cardiovascular events in patients with diabetic nephropathy?

Nature Clinical Practice Nephrology volume 2, pages 132–133 (2006)Cite this article

boxed-textBerl T et al. (2005) Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol 16: 2170–2179

In order to delay progression to end-stage renal disease and reduce the incidence of cardiovascular events, the target systolic blood pressure in patients with diabetic nephropathy should be <130 mmHg

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Lewis EJ et al. (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345: 851–860

    Article  CAS  Google Scholar 

  2. Berl T et al. (2003) Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Ann Intern Med 138: 542–549

    Article  CAS  Google Scholar 

  3. Turner R et al. for the UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317: 703–713

    Article  Google Scholar 

  4. Turnbull F et al. (2005) Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med 165: 1410–1419

    Article  Google Scholar 

  5. Chobanian AV et al. (2003) The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report. JAMA 289: 2560–2572

    Article  CAS  Google Scholar 

  6. European Society of Hypertension–European Society of Cardiology Guidelines Committee (2003) 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21: 1011–1053

  7. Savage PJ et al. (1998) Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group Arch Intern Med 158: 741–751

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloe Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Division and Department of Internal Medicine at the San Gerardo Hospital,

    Giuseppe Mancia

  2. Department of Clinical Medicine, Prevention and Applied Biotechnologies at the University of Milan-Bicocca, Monza, Italy

    Giuseppe Mancia

Authors
  1. Giuseppe Mancia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giuseppe Mancia.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mancia, G. What is the impact of blood-pressure control on cardiovascular events in patients with diabetic nephropathy?. Nat Rev Nephrol 2, 132–133 (2006). https://doi.org/10.1038/ncpneph0127

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0127

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing